INVO Fertility Inc [NASDAQ: IVF] traded at a high on 2025-07-22, posting a 35.69 gain after which it closed the day’ session at $3.46.
The results of the trading session contributed to over 52290084 shares changing hands. Over the past one week, the price volatility of INVO Fertility Inc stands at 17.32% while the volatility over the past one month is 12.98%.
The market cap for IVF stock reached $2.49 million, with 0.25 million shares outstanding. Compared to the average trading volume of 819.30K shares, IVF reached a trading volume of 52290084 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about INVO Fertility Inc [IVF]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for IVF shares is $18.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on IVF stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
How has IVF stock performed recently?
INVO Fertility Inc [IVF] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 43.83. With this latest performance, IVF shares dropped by -5.46% in over the last four-week period, additionally sinking by -81.25% over the last 6 months – not to mention a drop of -88.13% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for IVF stock in for the last two-week period is set at 57.96, with the RSI for the last a single of trading hit 0.43, and the three-weeks RSI is set at 0.46 for INVO Fertility Inc [IVF]. The present Moving Average for the last 50 days of trading for this stock 4.04, while it was recorded at 2.70 for the last single week of trading, and 15.71 for the last 200 days.
INVO Fertility Inc [IVF]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and INVO Fertility Inc [IVF] shares currently have an operating margin of -138.48% and a Gross Margin at 27.50%. INVO Fertility Inc’s Net Margin is presently recorded at -381.52%.
INVO Fertility Inc (IVF) Capital Structure & Debt Analysis
According to recent financial data for INVO Fertility Inc. ( IVF), the Return on Equity (ROE) stands at -679.99%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -99.49%, reflecting the company’s efficiency in generating profits from its assets. Additionally, INVO Fertility Inc’s Return on Invested Capital (ROIC) is -238.99%, showcasing its effectiveness in deploying capital for earnings.
INVO Fertility Inc (IVF) Efficiency & Liquidity Metrics
Based on INVO Fertility Inc’s (IVF) latest financial statements, the Debt-to-Equity Ratio is 1.21%, indicating its reliance on debt financing relative to shareholder equity.
INVO Fertility Inc (IVF) Efficiency & Liquidity Metrics
From an operational efficiency perspective, INVO Fertility Inc. (IVF) effectively leverages its workforce, generating an average of -$679729.73 per employee. The company’s liquidity position is robust, with a Current Ratio of 0.08% and a Quick Ratio of 0.07%, indicating strong ability to cover short-term liabilities.
Earnings analysis for INVO Fertility Inc [IVF]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for IVF. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for INVO Fertility Inc go to 60.65%.
Insider trade positions for INVO Fertility Inc [IVF]
There are presently around $4.10%, or 4.50% of IVF stock, in the hands of institutional investors.
